Norah Terrault, MD, MPH

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Norah Terrault, MD, MPH

Assistant Professor, Department of Medicine (Gastroenterology), UCSF

Phone: (415) 353-2318 (appts)
Box 0538, UCSF
San Francisco, CA 94143-0538

View on UCSF Profiles

Cancer Center Membership

Associate Member » Non-aligned

Additional Websites


Education

University of Alberta, MD, 1984-87
University of Toronto, FRCPC, 1988-92, Internal Medicine
University of Toronto, FRCPC, 1992-94, Gastroenterology
University of California, Berkeley, MPH, 1996-97, Epidemiology


Professional Experience

  • 1987-88 Comprehensive internship, University of Toronto
  • 1988-91
    Residency in Internal Medicine, University of Toronto
  • 1991-93
    Residency in Gastroenterology, University of Toronto
  • 1993-94
    Clinical Fellowship, University of Toronto
  • 1994-97
    Research Fellowship, University of California San Francisco
  • 1997-2002
    Adjunct Assistant Professor, Dept. of Medicine/Gastroenterology, University of California San Francisco
  • 2002-present
    Assistant Professor, Dept. of Medicine/Gastroenterology, University of California San Francisco

Honors & Awards

  • 1991
    Dr. D.H. Cowan, University of Toronto Teaching Award
  • 1992
    CAG Residents' Presentation Award
  • 1994
    CASL Presentation Award
  • 1994-96
    Canadian Liver Foundation Fellowship Award
  • 1996
    Canadian Liver Foundation Fellowship Award (declined)
  • 1996
    Medical Research Council of Canada Fellowship Award (declined)
  • 1996-8
    Dr. Saul Krugman Career Development Award
  • 1997-9
    Jan Albrecht Career Development Award

Selected Publications

  1. Terrault N. Difficult-to-cure populations with chronic hepatitis c: Vanishing in the direct-acting antiviral era? Hepatology. 2015 Jul; 62(1):4-7.
    View on PubMed
  2. Campos-Varela I, Lai JC, Verna EC, O'Leary JG, Todd Stravitz R, Forman LM, Trotter JF, Brown RS, Terrault NA. Hepatitis C Genotype Influences Post-liver Transplant Outcomes. Transplantation. 2015 Apr; 99(4):835-40.
    View on PubMed
  3. Price JC, Terrault NA. Treatment of hepatitis C in liver transplant patients: Interferon out, direct antiviral combos in. Liver Transpl. 2015 Apr; 21(4):423-34.
    View on PubMed
  4. Saxena V, Terrault NA. Hepatitis C direct antiviral drugs and hepatic decompensation in patients with advanced cirrhosis: culprit or innocent bystander? Dig Dis Sci. 2015 Apr; 60(4):806-9.
    View on PubMed
  5. Stock PG, Terrault NA. Human immunodeficiency virus and liver transplantation: Hepatitis C is the last hurdle. Hepatology. 2015 May; 61(5):1747-54.
    View on PubMed
  6. Ho CK, Maselli JH, Terrault NA, Gonzales R. High Rate of Hospital Admissions Among Patients with Cirrhosis Seeking Care in US Emergency Departments. Dig Dis Sci. 2015 Jul; 60(7):2183-9.
    View on PubMed
  7. Campos-Varela I, Straley S, Agudelo EZ, Carlson L, Terrault NA. Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients. Liver Transpl. 2015 Feb; 21(2):272-4.
    View on PubMed
  8. Di Bisceglie AM, Lok AS, Martin P, Terrault N, Perrillo RP, Hoofnagle JH. Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg? Hepatology. 2015 Feb; 61(2):703-11.
    View on PubMed
  9. Goel A, Terrault N. Reply. Liver Transpl. 2015 Mar; 21(3):416.
    View on PubMed
  10. Lai JC, Shoback DM, Zipperstein J, Lizaola B, Tseng S, Terrault NA. Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C. Dig Dis Sci. 2015 Jan 7.
    View on PubMed
  11. Price JC, Terrault NA. Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective. Liver Int. 2015 Jan; 35(1):7-8.
    View on PubMed
  12. Flemming JA, Kim WR, Terrault NA. Reply to prediction of hepatocellular carcinoma: Using a complex risk model or assisting for smoking cessation? Cancer. 2015 Apr 1; 121(7):1150.
    View on PubMed
  13. Sarkar M, Watt KD, Terrault N, Berenguer M. Outcomes in liver transplantation: does sex matter? J Hepatol. 2015 Apr; 62(4):946-55.
    View on PubMed
  14. Tejada-Strop A, Drobeniuc J, Mixson-Hayden T, Forbi JC, Le NT, Li L, Mei J, Terrault N, Kamili S. Disparate detection outcomes for anti-HCV IgG and HCV RNA in dried blood spots. J Virol Methods. 2015 Feb; 212:66-70.
    View on PubMed
  15. Kwo PY, Mantry PS, Coakley E, Te HS, Vargas HE, Brown R, Gordon F, Levitsky J, Terrault NA, Burton JR, Xie W, Setze C, Badri P, Pilot-Matias T, Vilchez RA, Forns X. An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med. 2014 Dec 18; 371(25):2375-82.
    View on PubMed
  16. Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, Chalasani N, Dasarathy S, Diehl AM, Hameed B, Kowdley KV, McCullough A, Terrault N, Clark JM, Tonascia J, Brunt EM, Kleiner DE, Doo E. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet. 2015 Mar 14; 385(9972):956-65.
    View on PubMed
  17. Miro JM, Stock P, Teicher E, Duclos-Vallée JC, Terrault N, Rimola A. Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update. J Hepatol. 2015 Mar; 62(3):701-11.
    View on PubMed
  18. Charlton M, Gane E, Manns MP, Brown RS, Curry MP, Kwo PY, Fontana RJ, Gilroy R, Teperman L, Muir AJ, McHutchison JG, Symonds WT, Brainard D, Kirby B, Dvory-Sobol H, Denning J, Arterburn S, Samuel D, Forns X, Terrault NA. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. Gastroenterology. 2015 Jan; 148(1):108-17.
    View on PubMed
  19. Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl. 2014 Oct; 20(10):1221-8.
    View on PubMed
  20. Curry MP, Forns X, Chung RT, Terrault NA, Brown R, Fenkel JM, Gordon F, O'Leary J, Kuo A, Schiano T, Everson G, Schiff E, Befeler A, Gane E, Saab S, McHutchison JG, Subramanian GM, Symonds WT, Denning J, McNair L, Arterburn S, Svarovskaia E, Moonka D, Afdhal N. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Gastroenterology. 2015 Jan; 148(1):100-107.e1.
    View on PubMed

Go to UCSF Profiles, powered by CTSI